These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30679156)

  • 1. A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8
    Duperret EK; Perales-Puchalt A; Stoltz R; G H H; Mandloi N; Barlow J; Chaudhuri A; Sardesai NY; Weiner DB
    Cancer Immunol Res; 2019 Feb; 7(2):174-182. PubMed ID: 30679156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.
    Sultan H; Takeuchi Y; Ward JP; Sharma N; Liu TT; Sukhov V; Firulyova M; Song Y; Ameh S; Brioschi S; Khantakova D; Arthur CD; White JM; Kohlmiller H; Salazar AM; Burns R; Costa HA; Moynihan KD; Yeung YA; Djuretic I; Schumacher TN; Sheehan KCF; Colonna M; Allison JP; Murphy KM; Artyomov MN; Schreiber RD
    Nature; 2024 Aug; 632(8023):182-191. PubMed ID: 39048822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
    Martin SD; Brown SD; Wick DA; Nielsen JS; Kroeger DR; Twumasi-Boateng K; Holt RA; Nelson BH
    PLoS One; 2016; 11(5):e0155189. PubMed ID: 27192170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH.
    Crowley SJ; Bruck PT; Bhuiyan MA; Mitchell-Gears A; Walsh MJ; Zhangxu K; Ali LR; Jeong HJ; Ingram JR; Knipe DM; Ploegh HL; Dougan M; Dougan SK
    Open Biol; 2020 Feb; 10(2):190235. PubMed ID: 32019478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes.
    Smith CC; Chai S; Washington AR; Lee SJ; Landoni E; Field K; Garness J; Bixby LM; Selitsky SR; Parker JS; Savoldo B; Serody JS; Vincent BG
    Cancer Immunol Res; 2019 Oct; 7(10):1591-1604. PubMed ID: 31515258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing neoantigen specific CD4 T cells for cancer immunotherapy.
    Brightman SE; Naradikian MS; Miller AM; Schoenberger SP
    J Leukoc Biol; 2020 Apr; 107(4):625-633. PubMed ID: 32170883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
    Barajas A; Amengual-Rigo P; Pons-Grífols A; Ortiz R; Gracia Carmona O; Urrea V; de la Iglesia N; Blanco-Heredia J; Anjos-Souza C; Varela I; Trinité B; Tarrés-Freixas F; Rovirosa C; Lepore R; Vázquez M; de Mattos-Arruda L; Valencia A; Clotet B; Aguilar-Gurrieri C; Guallar V; Carrillo J; Blanco J
    J Transl Med; 2024 Jan; 22(1):14. PubMed ID: 38172991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunogenic personal neoantigen vaccine for patients with melanoma.
    Ott PA; Hu Z; Keskin DB; Shukla SA; Sun J; Bozym DJ; Zhang W; Luoma A; Giobbie-Hurder A; Peter L; Chen C; Olive O; Carter TA; Li S; Lieb DJ; Eisenhaure T; Gjini E; Stevens J; Lane WJ; Javeri I; Nellaiappan K; Salazar AM; Daley H; Seaman M; Buchbinder EI; Yoon CH; Harden M; Lennon N; Gabriel S; Rodig SJ; Barouch DH; Aster JC; Getz G; Wucherpfennig K; Neuberg D; Ritz J; Lander ES; Fritsch EF; Hacohen N; Wu CJ
    Nature; 2017 Jul; 547(7662):217-221. PubMed ID: 28678778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth.
    Aurisicchio L; Salvatori E; Lione L; Bandini S; Pallocca M; Maggio R; Fanciulli M; De Nicola F; Goeman F; Ciliberto G; Conforti A; Luberto L; Palombo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):78. PubMed ID: 30764846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
    Rojas LA; Sethna Z; Soares KC; Olcese C; Pang N; Patterson E; Lihm J; Ceglia N; Guasp P; Chu A; Yu R; Chandra AK; Waters T; Ruan J; Amisaki M; Zebboudj A; Odgerel Z; Payne G; Derhovanessian E; Müller F; Rhee I; Yadav M; Dobrin A; Sadelain M; Łuksza M; Cohen N; Tang L; Basturk O; Gönen M; Katz S; Do RK; Epstein AS; Momtaz P; Park W; Sugarman R; Varghese AM; Won E; Desai A; Wei AC; D'Angelica MI; Kingham TP; Mellman I; Merghoub T; Wolchok JD; Sahin U; Türeci Ö; Greenbaum BD; Jarnagin WR; Drebin J; O'Reilly EM; Balachandran VP
    Nature; 2023 Jun; 618(7963):144-150. PubMed ID: 37165196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of multiepitope cancer vaccines based on large combinatorial libraries of survivin-derived mutant epitopes.
    Domínguez-Romero AN; Martínez-Cortés F; Munguía ME; Odales J; Gevorkian G; Manoutcharian K
    Immunology; 2020 Oct; 161(2):123-138. PubMed ID: 32619293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacy.
    Huff AL; Longway G; Mitchell JT; Andaloori L; Davis-Marcisak E; Chen F; Lyman MR; Wang R; Mathew J; Barrett B; Rahman S; Leatherman J; Yarchoan M; Azad NS; Yegnasubramanian S; Kagohara LT; Fertig EJ; Jaffee EM; Armstrong TD; Zaidi N
    JCI Insight; 2023 Dec; 8(23):. PubMed ID: 38063199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanoma.
    Xu W; de Zoeten E; Carr-Brendel V; Cohen EP
    Cancer Immunol Immunother; 1998 Jan; 45(5):217-24. PubMed ID: 9439644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled nanoparticles based on DNA origami and a nitrated T helper cell epitope as a platform for the development of personalized cancer vaccines.
    Kang Y; Zhang W; Yu Q; Gao L; Quan J; Gu F; Wu Y; Tian Y; Wu Z; Shao S; Zhou H; Duan S; Zhou Y; Zhang L; Gao X; Tian H; Yao W
    Cancer Immunol Immunother; 2023 Aug; 72(8):2741-2755. PubMed ID: 37119260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
    Mørk SK; Skadborg SK; Albieri B; Draghi A; Bol K; Kadivar M; Westergaard MCW; Stoltenborg Granhøj J; Borch A; Petersen NV; Thuesen N; Rasmussen IS; Andreasen LV; Dohn RB; Yde CW; Noergaard N; Lorentzen T; Soerensen AB; Kleine-Kohlbrecher D; Jespersen A; Christensen D; Kringelum J; Donia M; Hadrup SR; Marie Svane I
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38782542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neo-intline: integrated pipeline enables neoantigen design through the in-silico presentation of T-cell epitope.
    Li B; Jing P; Zheng G; Pi C; Zhang L; Yin Z; Xu L; Qiu J; Gu H; Qiu T; Fang J
    Signal Transduct Target Ther; 2023 Oct; 8(1):397. PubMed ID: 37848417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sites.
    Ghochikyan A; Mkrtichyan M; Loukinov D; Mamikonyan G; Pack SD; Movsesyan N; Ichim TE; Cribbs DH; Lobanenkov VV; Agadjanyan MG
    J Immunol; 2007 Jan; 178(1):566-73. PubMed ID: 17182597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity.
    Liu L; Chen J; Zhang H; Ye J; Moore C; Lu C; Fang Y; Fu YX; Li B
    Nat Cancer; 2022 Apr; 3(4):437-452. PubMed ID: 35393580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
    Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
    Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants for Neoantigen Identification.
    Garcia-Garijo A; Fajardo CA; Gros A
    Front Immunol; 2019; 10():1392. PubMed ID: 31293573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.